Prescribing

Supporting system response to the ADHD medicine shortage

1 November 2024Practical advice for the system in response to the NatPSA for Attention Deficit Hyperactivity Disorder (ADHD) medicines.

Continuing management of the ADHD medicines shortage

15 July 2024Support for the system in continuing to manage supply disruption of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD).

Using St Mark’s electrolyte solution

12 June 2024St Mark’s solution is an oral rehydration solution, which maintains fluid balance in conditions like short bowel syndrome. We guide on preparation and use.

Use of nefopam for chronic pain

30 January 2024Nefopam is licensed for chronic pain relief. However, evidence to support use is limited and is not included in national guidelines.

Example medicines to prescribe by brand name in primary care

21 June 2023Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.

Prescribing by generic or brand name in primary care

13 September 2022Prescribing medicines by generic name is generally preferred but there are some circumstances when brand-name prescribing is warranted.